0000899243-19-013542.txt : 20190515 0000899243-19-013542.hdr.sgml : 20190515 20190515145026 ACCESSION NUMBER: 0000899243-19-013542 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marlow DeeAnne J CENTRAL INDEX KEY: 0001641337 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12658 FILM NUMBER: 19827289 MAIL ADDRESS: STREET 1: 4250 CONGRESS STREET STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBEMARLE CORP CENTRAL INDEX KEY: 0000915913 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 541692118 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 CONGRESS STREET STREET 2: SUITE 700 CITY: CHARLOTTE STATE: NC ZIP: 28209 BUSINESS PHONE: 980-299-5700 MAIL ADDRESS: STREET 1: 4350 CONGRESS STREET STREET 2: SUITE 700 CITY: CHARLOTTE STATE: NC ZIP: 28209 FORMER COMPANY: FORMER CONFORMED NAME: ECHEM INC DATE OF NAME CHANGE: 19931208 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-05-07 0 0000915913 ALBEMARLE CORP ALB 0001641337 Marlow DeeAnne J ALBEMARLE CORPORATION, 4250 CONGRESS STREET, SUITE 900 CHARLOTTE NC 28209 0 1 0 0 SVP, Chief HR Officer Stock Option 91.00 Common Stock 5414 D Restricted Stock Units Common Stock 7326 D Restricted Stock Units Common Stock 1650 D On February 26, 2019, the reporting person was granted a ten-year option exercisable for 5,414 shares of Common Stock, cliff-vesting on February 26, 2022. Restricted Stock Units granted on 11/9/2018, fully vesting on 11/9/2021. No expiration date. Each Restricted Stock Unit converts into 1 share of Common Stock. Restricted Stock Units granted on 2/26/2019. First 50% vests on 2/26/2022 and second 50% vests on 2/26/2023. Exhibit 24 - Power of Attorney /s/ Ander Krupa, attorney-in-fact 2019-05-15 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                      EXHIBIT 24

                               POWER OF ATTORNEY

       Know all by these presents, that the undersigned hereby constitutes and
appoints each of Karen G. Narwold, Ander Krupa, Sarah E. Marshik and Brenda J.
Mareski, or either of them acting singly and with full power of substitution,
the undersigned's true and lawful attorney-in-fact to:

       (1)    execute for and on behalf of the undersigned, in the undersigned's
              capacity as an officer and/or director of Albemarle Corporation
              (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a)
              of the Securities Exchange Act of 1934 and the rules thereunder;

       (2)    do and perform any and all acts for and on behalf of the
              undersigned that may be necessary or desirable to complete and
              execute any such Form 3, 4 or 5, complete and execute any
              amendment or amendments thereto, and timely file such form with
              the United States Securities and Exchange Commission and any stock
              exchange or similar authority; and

       (3)    take any other action of any type whatsoever in connection with
              the foregoing that, in the opinion of such attorney-in-fact, may
              be of benefit to, in the best interest of, or legally required by,
              the undersigned, it being understood that the documents executed
              by such attorney-in-fact on behalf of the undersigned pursuant to
              this Power of Attorney shall be in such form and shall contain
              such terms and conditions as such attorney-in-fact may approve in
              such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 9th day of May, 2019.


                                               /s/ DeeAnne J. Marlow
                                               DeeAnne J. Marlow